Compare WKC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WKC | OCUL |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 1994 | 2014 |
| Metric | WKC | OCUL |
|---|---|---|
| Price | $35.67 | $9.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $28.00 | $23.56 |
| AVG Volume (30 Days) | 810.4K | ★ 1.9M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.96% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | ★ $36,916,600,000.00 | $1,990,000.00 |
| Revenue This Year | $0.62 | $7.93 |
| Revenue Next Year | $3.42 | $96.07 |
| P/E Ratio | $24.98 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $22.21 | $6.23 |
| 52 Week High | $41.20 | $16.44 |
| Indicator | WKC | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 50.45 | 42.58 |
| Support Level | $34.95 | $9.24 |
| Resistance Level | $36.39 | $9.93 |
| Average True Range (ATR) | 0.90 | 0.56 |
| MACD | 0.09 | -0.13 |
| Stochastic Oscillator | 59.20 | 5.28 |
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. It earns the majority of its revenue from the Aviation segment.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.